title: Jaundice in the newborns.
abstract: Hyperbilirubinemia is the commonest morbidity in the neonatal period and 5-10% of all newborns require intervention for pathological jaundice. Neonates on exclusive breast-feeding have a different pattern and degree of jaundice as compared to artificially fed babies. Latest guidelines from the American Academy of Pediatrics (AAP) for management of jaundice in a normal term newborn have been included in the protocol. Separate guidelines have been provided for the management of jaundice in sick term babies, preterm and low birth weight babies, for hemolytic jaundice and prolonged hyperbilirubinemia.
authors.affiliation: Division of Neonatology, Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
authors.forename: Satish
authors.initials: S
authors.lastname: Mishra
authors.forename: Ramesh
authors.initials: R
authors.lastname: Agarwal
authors.forename: Ashok K
authors.initials: AK
authors.lastname: Deorari
authors.forename: Vinod K
authors.initials: VK
authors.lastname: Paul
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use; D001663:Bilirubin / Q000032:analysis / Q000097:blood; D004359:Drug Therapy, Combination; D005078:Exchange Transfusion, Whole Blood / Q000379:methods; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D007231:Infant, Newborn; D007275:Injections, Intravenous; D007567:Jaundice, Neonatal / Q000097:blood / Q000175:diagnosis / Q000628:therapy; D010634:Phenobarbital / Q000627:therapeutic use; D010789:Phototherapy / Q000379:methods; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants; D007136:Immunoglobulins; D007155:Immunologic Factors; D001663:Bilirubin; D010634:Phenobarbital